H3D Vision & Mission
Vision: To be the leading organisation for integrated drug discovery and development on the African continent Mission: Discover and develop innovative, life saving medicines For African patients Through excellence in interdisciplinary,...
H3D Facilities
Facilities H3D has state of the art laboratory equipment and access to modern instrumentation housed in the Department of Chemistry, the Department of Clinical Pharmacology and the Institute of Infectious Disease and Molecular Medicine (IDM) at UCT...
R&D Environment
UCT offers a truly integrated environment for translational research in communicable and non communicable diseases afflicting people in Africa. It has both the infrastructure as well as numerous groups working on pre-clinical and clinical research...
Home > Home


Tuesday, 3 August 2021
H3D’s Prof Kelly Chibale Honoured as Leader in Biotech

H3D Founder and Director, Prof Kelly Chibale, was recently listed as one of the 22 Black leaders in Biotech in honour of Juneteenth. The list, published by the Timmerman Report, celebrates innovative black leaders who are change-makers in their respective fields. 

Publication Date:
Thu, 22 Jul 2021 - 07:45
H3D partners with Yemaachi to utilize African genetic diversity to develop new tools for improving treatment outcomes for the African patient populations

H3D has a new collaboration with Yemaachi,  a private research company based in Accra, Ghana, that is working towards lowering the economic burden of cancer on the African continent.

Image credit: africanhealthsciences.org

Publication Date:
Wed, 02 Jun 2021 - 07:45
H3D partners with Ersilia Open Source Initiative (EOSI) to apply AI/ML to the drug discovery pipeline

H3D is partnering with Ersilia Open Source Initiative (EOSI), a UK-based non-profit organization specializing in artificial intelligence (AI)/ machine learning (ML) for drug discovery.  

Image: Yuichiro Chino/Getty Images

Publication Date:
Mon, 31 May 2021 - 07:45
H3D receives SAMRC grant for COVID-19 research project

H3D is very excited to be part of the BRICS and international fight against  COVID-19 with our successfully awarded proposal "Multidisciplinary platform based on artificial intelligence for accelerating drug discovery and repurposing for COVID-19".

Publication Date:
Tue, 18 May 2021 - 07:45